LUCD
Lucid Diagnostics Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.94
−1.23%Aug 13, 2026, 14:11 UTC
Lucid Diagnostics Inc. reported a Q2 2026 loss of $0.06 per share, missing the Zacks Consensus Estimate of a $0.04 loss and improving from a $0.10 loss a year earlier.
Source: